Epinastine in the management of ocular allergic disease

International Ophthalmology Clinics

Volumn 46, Issue 4, 2006, Pages 85-86

  Friedlaender, Mitchell H ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPINASTINE; OLOPATADINE; PLACEBO;

ALLERGIC CONJUNCTIVITIS; BLOOD BRAIN BARRIER; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; EYE ALLERGY; HUMAN; OCULAR PRURITUS; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT INDICATION;

CONJUNCTIVITIS, ALLERGIC; DIBENZAZEPINES; HISTAMINE H1 ANTAGONISTS; HUMANS; IMIDAZOLES; OPHTHALMIC SOLUTIONS; TREATMENT OUTCOME;

EID: 33750326344     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000212128.45395.a5     Document Type: Short Survey

References (7)

1. Bielory L, Ghafoor S. Histamine receptors and the conjunctiva. Curr Opin Allergy Immunol. 2005;5:437-440.
2. Bielory L, Lien KW, Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs. 2005;65:215-228.
3. Abelson MB, Gomes P, Crampton HJ, et al. Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis. Clin Ther. 2004;26:35-47.
4. Whitcup SM, Bradford R, Lue J, et al. Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis. Clin Ther. 2004;26:29-34.
5. Fraunfelder FW. Epinastine hydrochloride for atopic disease. Drugs Today. 2004;40:677-683.
6. Furue M, Terao H, Koga T. Effects of cetirizine and epinastine on the skin response to histamine iontophoresis. J Dermatol Sci. 2001;25:59-63.
7. Grant JA, Danielson L, Rihoux JP, et al. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. Allergy. 1999;54:700-707.